Abstract:STARR-seq and other massively-parallel reporter assays are widely used to discover functional enhancers in transfected cell models, which can be confounded by plasmid vector-induced type-I interferon immune responses and lack the multicellular environment and endogenous chromatin state of complex mammalian tissues. Here, we describe HDI-STARR-seq, which combines STARR-seq plasmid library delivery to the liver, by hydrodynamic tail vein injection (HDI), with reporter RNA transcriptional initiation driven by a minimal Albumin promoter, which we show is essential for mouse liver STARR-seq enhancer activity assayed 7 days after HDI. Importantly, little or no vector-induced innate type-I interferon responses were observed. Comparisons of HDI-STARR-seq activity between male and female mouse livers and in livers from males treated with an activating ligand of the transcription factor CAR (Nr1i3) identified many condition-dependent enhancers linked to condition-specific gene expression. Further, thousands of active liver enhancers were identified using a high complexity STARR-seq library comprised of ~50,000 genomic regions released by DNase-I digestion of mouse liver nuclei. When compared to stringently inactive library sequences, the active enhancer sequences identified were highly enriched for liver open chromatin regions with activating histone marks (H3K27ac, H3K4me1, H3K4me3), were significantly closer to gene transcriptional start sites, and were significantly depleted of repressive (H3K27me3, H3K9me3) and transcribed region histone marks (H3K36me3). HDI-STARR-seq offers substantial improvements over current methodologies for large scale, functional profiling of enhancers, including condition-dependent enhancers, in liver tissue in vivo, and can be adapted to characterize enhancer activities in a variety of species and tissues by selecting suitable tissue- and species-specific promoter sequences.

How Useful is Basal Renal Tubular Epithelial Cell Vacuolization as a Marker for Significant Hyperglycemia at Autopsy?

Underlying causes for prevalent false positives and false negatives in STARR-seq data

The Application of the High Throughput Sequencing Technology in the Transposable Elements

STARR-seq and UMI-STARR-seq: Assessing Enhancer Activities for Genome-Wide-, High-, and Low-Complexity Candidate Libraries

Functional assessment of human enhancer activities using whole-genome STARR-sequencing

Inference of Transcriptional Regulation From STARR-seq Data

STARRPeaker: uniform processing and accurate identification of STARR-seq active regions

Chromatin Potential Identified by Shared Single Cell Profiling of RNA and Chromatin

Identification of Highly Repetitive Enhancers with Long-range Regulation Potential in Barley via STARR-seq

Global Quantitative Mapping of Enhancers in Rice by STARR-seq

Proceedings: Studies in the role of the colon in urea metabolism.

HDI-STARR-seq: Condition-specific enhancer discovery in mouse liver in vivo

A comparison of experimental assays and analytical methods for genome-wide identification of active enhancers

ATAC-STARR-seq reveals transcription factor-bound activators and silencers within chromatin-accessible regions of the human genome

Effect of testosterone and duct ligation on submaxillary renin-like principle.

Nascent RNA sequencing analysis provides insights into enhancer-mediated gene regulation

Predicting active enhancers with DNA methylation and histone modification

Enhancer-driven gene regulatory networks inference from single-cell RNA-seq and ATAC-seq data

Enhancer RNAs: a missing regulatory layer in gene transcription

Transcriptional regulation by promoters with enhancer function

Demystifying the secret mission of enhancers: linking distal regulatory elements to target genes